Navigation Links
M2S Announces Agreement with AG Mednet to Provide Clinical Trial Sponsors with More Options for Efficient Image Transfer and Collection
Date:4/7/2009

M2S Inc., a global provider of image management services for biopharmaceutical and medical device clinical trials, today announced that it had entered into an agreement with AG Mednet, a HIPAA and 21 CFR Part 11 compliant diagnostic imaging exchange network. The agreement will allow M2S to offer clinical trial sponsors more options for efficient, cost-effective image collection and transfer.

(PRWEB) April 7, 2009 -- M2S Inc., a global provider of image management services for biopharmaceutical and medical device clinical trials, today announced that it had entered into an agreement with AG Mednet, a HIPAA and 21 CFR Part 11 compliant diagnostic imaging exchange network.

The agreement will allow M2S to offer clinical trial sponsors more options for efficient, cost-effective image collection and transfer.

"Our agreement with AG Mednet significantly expands our service offerings for clinical trials image management," said Wes Chapman, CEO of M2S. "It enables us to provide image collection and transfer services based on the unique needs of each trial. In addition, the AG Mednet solution is a perfect complement to our DICOM Armor Car® (DAC) and other image transfer technologies."

Chapman also noted that by offering expanded image collection and transfer options, M2S can help sponsors save both time and money. "In an era of immense cost pressures, M2S is proud to be the only imaging core lab able to offer rapid and high-quality imaging data through both hardware and software-based options while also providing measurable time and cost savings," he stated.

Abraham Gutman, President & CEO of AG Mednet added that his company is pleased to be working with M2S.

"The AG Mednet web-enabled network, together with its powerful workflow and de-identification capabilities, is rapidly becoming the standard software-based image delivery platform, and will provide M2S with a highly scalable solution to fit the needs of the most demanding global trials," said Gutman.

Clinical trials are increasingly using medical imaging for inclusion criteria, secondary and surrogate endpoints and to serve as adjunctive safety assessment of drugs under development. Imaging provides a non-invasive method of obtaining information on a drug's effects in the body and can provide crucial information for making early "go/no-go" decisions, potentially saving millions of dollars in development costs. Collecting and managing large amounts of imaging data securely and rapidly can be challenging and often costly for trial sponsors, and the traditional method of image transfer via hard media and courier services is very time-intensive and error prone. Electronic data transfer of images drastically reduces the time involved, provides the opportunity for early discovery and resolution of queries, and therefore can provide significant cost savings in clinical trials.

M2S has been utilizing web-based methods for rapid and secure electronic image collection and transfer since 2002, with their proprietary network transfer device, the DICOM Armor Car (DAC®), which has an installed base of 287 sites worldwide. The AG Mednet network, in use at over 600 investigator sites globally, provides a web-enabled site interface allowing investigators to de-identify exams, fill electronic transmittal forms and submit the data directly to M2S trial repositories. Whether a trial is a Phase I using imaging for inclusion criteria, or a Phase III multi-center international study with multiple imaging modalities for surrogate endpoints, M2S has the technology and process combination to provide the best customized solution.

About M2S, Inc.
M2S is a full-service imaging CRO, providing high-quality, timely and cost-effective image data management services for clinical trial sponsors in the biopharmaceutical and medical device industries as well as patient registry databases. For the past 10 years, M2S has managed, under protocol, over 150 million images from around the globe in all major therapeutic areas and in all DICOM modalities. For more information, visit www.m2s.com.

About AG Mednet, Inc.
AG Mednet, Inc. is a global diagnostic imaging network. Pharmaceutical, biotech and medical device companies, core labs and clinical research organizations utilizing imaging technology as part of their trial protocol rely on AG Mednet's automated system to enable the secure electronic transfer of cases from hundreds of locations, enhancing site compliance while providing detailed reporting necessary to meet the most stringent regulatory requirements. Additional information about AG Mednet is available at www.agmednet.com

###

Read the full story at http://www.prweb.com/releases/clinical/trials/prweb2303234.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Immucor Announces Fiscal Third Quarter Results
2. IGI Announces Portal Designed to Maximize Data Sharing Between Hospitals and Their Affiliated Physicians
3. iMedica Announces New Leadership for Regional Sales Teams
4. TeleTracking Announces Next Generation Bed Management Solution at HIMSS 09
5. Haemonetics Announces Change to Board of Directors
6. Cord Blood Announces $1.75 Million Reduction in Long Term Debt
7. FFF Named the Exclusive Distributor of Fluzone for GPOs & Announces New Fluzone Return Policy
8. Siemens Announces Latest Contracts, Recent Go Lives, and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009
9. Schiff Announces New Trip of a Lifetime Sweepstakes
10. Male Hormone Treatment Provider Announces Family Doctor Alert
11. Microsoft Windows Embedded Announces Winner of SPARKs Will Fly Developer Contest
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
M2S Announces Agreement with AG Mednet to Provide Clinical Trial Sponsors with More Options for Efficient Image Transfer and Collection
(Date:2/8/2016)... , ... February 08, 2016 , ... ... only four states in the U.S. require dental technicians to be certified or ... the dental industry, NADL created the “What’s In Your Mouth?” campaign to inform ...
(Date:2/7/2016)... ... February 07, 2016 , ... Women's Excellence staff, in all four locations, wore ... Wear Red Day is the first Friday each February and a day to bring ... in 3 deaths among women each year – more than all cancers combined. Go ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... Plastics, has added Kybella® to his medical and surgical expertise. Technically known as ... FDA injectable medication used as a non-surgical alternative for reduction of fat below ...
(Date:2/6/2016)... San Rafael, CA (PRWEB) , ... February 06, 2016 , ... ... 2016 Youth Ultimate Coaching Conference (YUCC) . This event brings together top non-profit leaders, ... is “Gender Equity and Girls Ultimate”. Valerio Iani, Bay Area Disc Program Director of ...
(Date:2/6/2016)... ... 06, 2016 , ... Shark Finds and Kevin Harrington, along with ... DRTV campaign with Belly Bands. , Having a dog is great—except when it wets ... and find nothing works, get Belly Bands, the easiest way to stop dogs ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... 2016  Labvantage Lx, a newcomer to the ... sexual enhancement product, EnduramenT. Setting a new standard ... a patented biomedical breakthrough molecule that promotes the ... responsible for many biological functions including erectile function. ... Forgoing the use of prescription medications, scientists working ...
(Date:2/8/2016)... 2016  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... quarter and year-end 2015 results after the Nasdaq market ... host a live conference call and webcast to discuss ... afternoon, February 11, 2016 at 4:30 p.m. Eastern Time ... --> http://www.neurocrine.com . --> Participants can ...
(Date:2/8/2016)... 2016 --> ... "Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, ... Surgery, Ophthalmology, Gynecology) - Global Forecasts to 2020", published ... the forecast period of 2015 to 2020. The market ... CAGR of 10.5% from 2015 to 2020. ...
Breaking Medicine Technology: